Rehaneo has secured Fremman Capital as a majority shareholder, aiming to enhance its outpatient rehabilitation services and drive growth through strategic acquisitions in a fragmented market.

Information on the Target

Rehaneo, established in 2020, is a prominent provider of outpatient rehabilitation, aftercare, prevention, and occupational health management in Germany. The company has experienced significant growth since its inception, particularly during the COVID-19 pandemic, evolving into one of the top three providers in its sector. Founders Bruno Crone and Christoph Dühr, who maintain substantial stakes in the business, continue to lead the organization while effectively managing its expansion.

Under the guidance of Gimv, the previous majority shareholder, rehaneo has successfully integrated 13 companies across 23 locations nationwide. Its recent establishment of a new center in Göttingen showcases its commitment to accessible rehabilitation services. Currently, rehaneo employs over 1,000 professionals dedicated to serving more than 80,000 patients annually across various offerings, including outpatient rehabilitation, aftercare, physiotherapy, and occupational therapy.

Industry Overview in Germany

In Germany, the outpatient rehabilitation industry is witnessing a strong demand driven by patient preferences for consistent care within familiar environments. Compared to inpatient care, outpatient rehabilitation services a

View Source

Similar Deals

STARTIME MED GmbH Kröger Medical Personaldienstleistungen GmbH

2025

Management Buyout / Buy-In (MBO) Hospitals, Clinics & Primary Care Services Germany
Elliott Advisors (UK) Limited SYNLAB AG

2024

Management Buyout / Buy-In (MBO) Medical & Diagnostic Laboratories Germany
PINOVA Capital GmbH NEUROMEDEX

2024

Management Buyout / Buy-In (MBO) Medical Equipment, Supplies & Distribution (NEC) Germany
NORD Holding ABJ alive GmbH

2024

Management Buyout / Buy-In (MBO) Alternative Medicine Facilities Germany
aesco solutions group seleon GmbH

2024

Management Buyout / Buy-In (MBO) Medical Equipment, Supplies & Distribution (NEC) Germany
Novum Capital HECHT Contactlinsen GmbH

2024

Management Buyout / Buy-In (MBO) Glasses, Spectacles & Contact Lenses Germany

Fremman Capital

invested in

rehaneo

in 2024

in a Management Buyout / Buy-In (MBO) deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert